Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ikumi Soeda"'
Autor:
Takahiro Ichikawa, Masahiro Shibata, Takahiro Inaishi, Ikumi Soeda, Mitsuro Kanda, Masamichi Hayashi, Yuko Takano, Dai Takeuchi, Nobuyuki Tsunoda, Yasuhiro Kodera, Toyone Kikumori
Publikováno v:
Current Oncology, Vol 28, Iss 5, Pp 4080-4092 (2021)
Background: Accumulating evidence indicates tumor-promoting roles of synaptotagmin 13 (SYT13) in several cancers; however, no studies have investigated its expression in breast cancer (BC). This study aimed to clarify the significance of SYT13 in BC.
Externí odkaz:
https://doaj.org/article/c3267accee694af9a7c295464eec3b90
Autor:
Toyone Kikumori, Dai Takeuchi, Yasuhiro Kodera, Takahiro Inaishi, Takahiro Ichikawa, Ikumi Soeda, Masamichi Hayashi, Yuko Takano, Masahiro Shibata, Mitsuro Kanda, Nobuyuki Tsunoda
Publikováno v:
Current Oncology, Vol 28, Iss 346, Pp 4080-4092 (2021)
Current Oncology
Volume 28
Issue 5
Pages 346-4092
Current Oncology
Volume 28
Issue 5
Pages 346-4092
Background: Accumulating evidence indicates tumor-promoting roles of synaptotagmin 13 (SYT13) in several cancers
however, no studies have investigated its expression in breast cancer (BC). This study aimed to clarify the significance of SYT13 in
however, no studies have investigated its expression in breast cancer (BC). This study aimed to clarify the significance of SYT13 in
Autor:
Masahiro Shibata, Ikumi Soeda, Yasuhiro Kodera, Takahiro Inaishi, Takahiro Ichikawa, Masamichi Hayashi, Yuko Takano, Dai Takeuchi, Nobuyuki Tsunoda, Mitsuro Kanda, Toyone Kikumori
Publikováno v:
Oncology Reports. 47
The platelet isoform of phosphofructokinase (PFKP) is one of the key enzymes in the glycolytic pathway. PFKP is highly expressed in several cancers, and it has been reported to be involved in the progression of cancer cells. However, its oncological
Autor:
Nobuyuki Tsunoda, Ikumi Soeda, Toyone Kikumori, Dai Shimizu, Yuko Takano, Dai Takeuchi, Takahiro Inaishi, Takahiro Ichikawa, Masahiro Shibata
Publikováno v:
Surgery today. 51(10)
Papillary thyroid cancer (PTC) is generally associated with a favorable prognosis. However, some patients have fatal disease, with locally infiltrating tumors or progressive distant metastases; yet few studies have investigated the characteristics of
Autor:
Dai Takeuchi, Yasuhiro Kodera, Noriyuki Miyajima, Takahiro Ichikawa, Nobuyuki Tsunoda, Ikumi Soeda, Mitsuro Kanda, Takahiro Inaishi, Toyone Kikumori, Yuko Takano, Masato Nagino, Manabu Watanabe, Masahiro Shibata
Publikováno v:
Oncology Letters
Breast cancer (BC) is the most common malignant tumor in females. Development of novel biomarkers or therapeutic targets may contribute toward the improvement of a patient's prognosis. Marginal zone B and B1 cell-specific protein (MZB1) is an unfolde
Autor:
Yoshichika Okamoto, Ikumi Soeda, Tomonori Tsuchiya, Masanori Sando, Masaki Terasaki, Kiyoshi Suzumura
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 78:260-264
Autor:
MANABU WATANABE, MASAHIRO SHIBATA, TAKAHIRO INAISHI, TAKAHIRO ICHIKAWA, IKUMI SOEDA, NORIYUKI MIYAJIMA, YUKO TAKANO, DAI TAKEUCHI, NOBUYUKI TSUNODA, MITSURO KANDA, TOYONE KIKUMORI, YASUHIRO KODERA, MASATO NAGINO
Publikováno v:
Oncology Letters; Nov2020, Vol. 20 Issue 5, p1-9, 9p
Autor:
Yoriko Ota, Yoshihiro Maruo, Hiroshi Sato, Yu Mimura, Asami Mori, Noriko Nishikura, Ikumi Soeda, Yoshihiro Takeuchi, Hiroko Takahashi, Katsuyuki Matsui
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 93:4261-4267
Context: Mutations in dual oxidase (DUOX2) have been proposed as a cause of congenital hypothyroidism. Previous reports suggest that biallelic mutations of DUOX2 cause permanent congenital hypothyroidism and that monoallelic mutations cause transient